Table 3

Spearman partial correlations among controls: adipokine concentrations at 10–14 GWs with glucose metabolism and cardiometabolic markers at 15–26 GWs

HOMA-IRGlucoseInsulinC-peptidehsCRPHDLDLDLDTGs
FABP40.160.25**0.17*0.27**0.32***−0.24**0.050.13
Chemerin0.020.090.030.100.26**−0.050.080.17*
IL-60.30***0.080.31***0.29***0.16*0.08−0.02−0.02
Leptin0.30***0.22**0.33***0.39***0.48***−0.130.100.07
sOB-R−0.27***−0.27**−0.30***−0.36***−0.24**0.25**0.09−0.13
Adiponectin−0.22**−0.29***−0.24**−0.28**−0.120.36***−0.01−0.27***
HMW-adiponectin−0.23**−0.31***−0.24**−0.29**−0.110.34***−0.01−0.30**
Omentin-1−0.19*−0.06−0.21*−0.21*−0.010.130.00−0.14*
Vaspin0.030.100.030.03−0.07−0.120.030.07
RBP40.000.070.000.07−0.08−0.020.14*0.25**

  • *P<0.05; **p<0.01; ***p<0.001; adjusts for age, GW of blood collection, nulliparity, and family history of diabetes.

  • FABP4, fatty acid binding protein-4; GW, gestational week; HDLD, high-density lipoprotein; HMW-adiponectin, high-molecular weight-adiponectin; HOMA-IR, homeostatic model assessment of insulin resistance; hsCRP, high-sensitivity C-reactive protein; IL-6, interleukin-6; LDLD, low-density lipoprotein; RBP4, retinol binding protein-4; sOB-R, soluble leptin receptor; TGs, triglycerides.